TY - JOUR
T1 - Digital image analysis of cd8+ and cd3+ tumor-infiltrating lymphocytes in tongue squamous cell carcinoma
AU - Huang, Yenlin
AU - Lin, Chieh
AU - Kao, Huang Kai
AU - Hung, Shao Yu
AU - Ko, Hung Ju
AU - Huang, Yu Chen
AU - Chang, Yu Liang
AU - Chang, Kai Ping
N1 - Publisher Copyright:
© 2020 Huang et al.
PY - 2020
Y1 - 2020
N2 - Purpose: The presence of CD8+ tumor-infiltrating lymphocytes (TILs) has been reported to be associated with treatment outcomes in many types of solid tumors. However, the results vary due to the various methods of visual estimation and subjective interpretation. The current study is the first to use digital image analyses to evaluate the density of CD8 +/CD3+ TILs in tongue squamous cell carcinoma (TSCC). Patients and Methods: From 2005 to 2015, a cohort of 258 TSCC patients were consecutively enrolled in this study. After immunohistochemistry on representative sections, the density of CD8+/CD3+ TILs at tumor invasive margins was evaluated by digital image analysis. The subjects were stratified by the median values of CD3+ cell density, CD8+ cell density, CD8/CD3, and scores (0, 1, and 2) to demonstrate the association with various clinicopathological manifestations. Results: Low CD8+ TIL counts were associated with advanced tumor stages (p=0.034), and low CD8/CD3 ratios were associated with perineural invasion (p=0.043). Both parameters were also associated with increased tumor depths (p=0.034 and 0.004, respectively). Univariate analyses revealed that advanced tumor stages, perineural invasion, extranodal extension, tumor depth, lower CD8 counts, and lower scores (score 0 vs 2) were associated with poorer overall survival, and multivariate analysis further indicated that extranodal extension and low scores (score 0 vs 2) were both independent factors for overall survival (p < 0.0001 and p = 0.0369, respectively). Conclusion: The use of digital image analysis to assess CD8+ TILs at the invasive margins provides an objective indicator of prognoses including overall survival.
AB - Purpose: The presence of CD8+ tumor-infiltrating lymphocytes (TILs) has been reported to be associated with treatment outcomes in many types of solid tumors. However, the results vary due to the various methods of visual estimation and subjective interpretation. The current study is the first to use digital image analyses to evaluate the density of CD8 +/CD3+ TILs in tongue squamous cell carcinoma (TSCC). Patients and Methods: From 2005 to 2015, a cohort of 258 TSCC patients were consecutively enrolled in this study. After immunohistochemistry on representative sections, the density of CD8+/CD3+ TILs at tumor invasive margins was evaluated by digital image analysis. The subjects were stratified by the median values of CD3+ cell density, CD8+ cell density, CD8/CD3, and scores (0, 1, and 2) to demonstrate the association with various clinicopathological manifestations. Results: Low CD8+ TIL counts were associated with advanced tumor stages (p=0.034), and low CD8/CD3 ratios were associated with perineural invasion (p=0.043). Both parameters were also associated with increased tumor depths (p=0.034 and 0.004, respectively). Univariate analyses revealed that advanced tumor stages, perineural invasion, extranodal extension, tumor depth, lower CD8 counts, and lower scores (score 0 vs 2) were associated with poorer overall survival, and multivariate analysis further indicated that extranodal extension and low scores (score 0 vs 2) were both independent factors for overall survival (p < 0.0001 and p = 0.0369, respectively). Conclusion: The use of digital image analysis to assess CD8+ TILs at the invasive margins provides an objective indicator of prognoses including overall survival.
KW - Oral cancer
KW - Oral cavity
KW - SCC
KW - Squamous cell carcinoma
KW - TIL
KW - Tumor-infiltrating lymphocyte
UR - http://www.scopus.com/inward/record.url?scp=85090624880&partnerID=8YFLogxK
U2 - 10.2147/CMAR.S255816
DO - 10.2147/CMAR.S255816
M3 - 文章
AN - SCOPUS:85090624880
SN - 1179-1322
VL - 12
SP - 8275
EP - 8285
JO - Cancer Management and Research
JF - Cancer Management and Research
ER -